Specific Lung Squamous Cell Carcinoma Prognosis-Subtype Distinctions Based on DNA Methylation Patterns

Area of Science:

• Oncology
• Genetics
• Epigenetics

Background:

• Lung squamous cell carcinoma (LUSC) is a major non-small-cell lung cancer subtype.
• Epigenetic alterations, particularly DNA methylation, are linked to cancer development and progression.

Purpose of the Study:

• To identify prognostic subgroups in LUSC using DNA methylation data.
• To correlate these subgroups with clinical characteristics.
• To develop a predictive model for LUSC patient prognosis.

Main Methods:

• Utilized DNA methylation array data from The Cancer Genome Atlas (TCGA) database.
• Applied consensus clustering to stratify patients into subgroups.
• Employed multivariate Cox proportional risk regression for model construction.

Main Results:

• Identified 196 significant DNA methylation sites associated with LUSC prognosis.
• Stratified patients into 7 distinct prognostic subgroups.
• Developed a predictive model using 3 subgroup-specific methylation sites, demonstrating high efficacy.

Conclusions:

• Established a novel classification of LUSC into 7 molecular subtypes based on DNA methylation.
• Demonstrated that molecular subtypes are independent prognostic factors in LUSC.
• Highlighted the potential of identified methylation sites and genes as biomarkers for diagnosis, therapy, and prognosis.